How much significant is this news? - Cure Parkinson's

Cure Parkinson's

26,491 members27,905 posts

How much significant is this news?

Farooqji profile image
22 Replies

Annovis Bio Inc. (ANVS) announces patients treated with ANVS401 for 25 days showed statistically significant cognitive improvement as measured by the Alzheimer’s Disease Scale

This is the first double-blind, placebo-controlled study that shows cognitive improvements in AD patients as measured by ADAS-Cog and functional improvements in PD patients as measured by the Unified Parkinson's Disease Rating Scale (UPDRS)

streetinsider.com/dr/news.p...

Written by
Farooqji profile image
Farooqji
To view profiles and participate in discussions please or .
Read more about...
22 Replies
redhawk1 profile image
redhawk1

At first look . . . very positive report! The market likes the outcome of the study!! Great to hear good news!!

jimcaster profile image
jimcaster

Anything which appears to show benefits to actual human beings and not just in fruit flies, worms, mice, rats, or monkeys is exciting to me. Thanks for sharing!

Kia17 profile image
Kia17 in reply tojimcaster

Unfortunately scientists only have deals with the fruit flies, worms, mice and rats to keep them healthy but not humans 😆

Double-blind, placebo-controlled studies are good!

Stephan12 profile image
Stephan12

it was double-blinded, but it was not really placebo-controlled. I was told that the dose I received might be 5, 10, 20, or 40 mg of Posiphen (Synonyms: ANVS-401, (+)-phenserine, Posiphen tartrate .) Maybe they consider a 5 mg dose as a placebo. alzforum.org/therapeutics/p...

Farooqji profile image
Farooqji in reply toStephan12

Thanks for sharing. Did you feel any improvement?

Stephan12 profile image
Stephan12 in reply toFarooqji

mentally - yes, but my balance became worse. I don't know how much it is related to the medicine and I don't know what dose I consumed

Farooqji profile image
Farooqji in reply toStephan12

Will you continue with the trial?

Skydome profile image
Skydome in reply toStephan12

Were PwP participants taking their usual PD meds at the same time? Thank you for sharing.

Stephan12 profile image
Stephan12 in reply toSkydome

yes

Mimer profile image
Mimer in reply toStephan12

"my balance became worse"

I'm in a positive mode today and speculate that it might be a recovery symptom from the treatment. If the neural pathways are cleaned up, it might be that the signals to (and feedback from) the muscles become stronger. So it may take some time for the CNS to adapt . I would have focused on balance training for a period to see if improves.

HugoRipanykhazov profile image
HugoRipanykhazov in reply toStephan12

how much of this news relates to PD? I saw the features as well and thought it only related to Alzheimers?

Stephan12 profile image
Stephan12 in reply toHugoRipanykhazov

they believe that every patient is a type of unique mix of Alz and PD

Farooqji profile image
Farooqji in reply toHugoRipanykhazov

Among the enrolled patients, half were pwp

Mimer profile image
Mimer in reply toStephan12

"it was double-blinded, but it was not really placebo-controlled. I was told that the dose I received might be 5, 10, 20, or 40 mg of Posiphen"

Thanks for sharing. Always interesting to hear first hand info from a participant.

I wonder if it could be that you were not among the first 14 PD, but in the second group of 40 to investigate optimal dose?

"The first 14 PD plus 14 AD patients, whose data are reported here, have finished treatment and their biomarkers are being measured. Recently, Annovis Bio reported the results of the measurement of inflammation in the first 14 PD patients using four biomarkers. The last 40 patients are being treated with different doses to determine the optimal dose. The study compares, in both patient populations, how nerve cells die by measuring all the steps in the toxic cascade leading to nerve cell death and how ANVS401 reverses the toxic cascade and recovers normal brain and body function."

"This interim analysis includes data from the first 14 Parkinson’s patients who have completed treatment; nine were given ANVS401, and five received placebo."

parkinsonsnewstoday.com/202...

Farooqji profile image
Farooqji

Annovis Bio claims wins in Alzheimer's and Parkinson's, shares skyrocket; FDA delays decision for Omeros' narsoplimabendpts.com/annovis-bio-clai...

Stephan12 profile image
Stephan12

I would like to participate in the next trial, but very unlikely will be accepted, plus I had to travel to another town - 3 hours flight - three (3) times during one month :(

Farooqji profile image
Farooqji in reply toStephan12

Thanks, wish you best of luck. If I were in your place, I would prefer to join the next phase as well

redhawk1 profile image
redhawk1 in reply toStephan12

Keep us updated, Stephen! Thank you for your service to the PD and AD communities!

Bolt_Upright profile image
Bolt_Upright in reply toStephan12

It seems to me that if you participate in a trial you should be allowed to continue with the best guess of the proper dosage for as long as you like. That would provide multiple long term single participant open label trials to gather more info (and it just seems right).

in reply toStephan12

Hello, were you able to continue with the next trial?

Canddy profile image
Canddy

Seems like good news, lets hope the results that will be released in July/August of this year remain positive. Thanks for posting!

Not what you're looking for?

You may also like...

Oral ANVS401 Improves Patients’ Motor Skills in Phase 2 Trial

' Once-a-day treatment with oral ANVS401 was found to significantly improve motor skills among...

Caloric Vestibular Stimulation seems very promising

Caloric Vestibular Stimulation seems very promising: Cholinergic system changes in...
Bolt_Upright profile image

Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s Disease

Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s...

Benfotiamine (Fat Soluble Form Of Vitamin B1) and AD

Benfotiamine has previously been discussed on this forum regarding PD and this recent study...
chartist profile image

The naturally occurring molecule N-acetylcysteine (NAC) shows benefit in a clinical trial for Parkinson's Disease.

N-acetylcysteine (NAC) is a naturally occurring molecule that replenishes one of the body's...
Farooqji profile image

Moderation team

See all
CPT_Aleksandra profile image
CPT_AleksandraAdministrator
CPT_Anaya profile image
CPT_AnayaAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.